BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11375803)

  • 1. Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells.
    Weiss JM; Oltmanns K; Gürke EM; Polack S; Eick F; Felberbaum R; Diedrich K; Ortmann O
    Eur J Endocrinol; 2001 Jun; 144(6):677-85. PubMed ID: 11375803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells.
    Weiss JM; Krautmacher B; Polack S; Diedrich K; Ortmann O
    Eur J Endocrinol; 2003 Jul; 149(1):31-7. PubMed ID: 12824863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells.
    Demirel LC; Weiss JM; Polack S; Unlü C; Diedrich K; Ortmann O
    Fertil Steril; 2000 Nov; 74(5):1001-7. PubMed ID: 11056249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cetrorelix and triptorelin on the viability and steroidogenesis of cultured human granulosa luteinized cells.
    Metallinou C; Köster F; Diedrich K; Nikolettos N; Asimakopoulos B
    In Vivo; 2012; 26(5):835-9. PubMed ID: 22949598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone and triptorelin inhibit the follicle stimulating hormone-induced response in human primary cultured granulosa-lutein cells.
    Furger C; Bourrié N; Cedard L; Ferré F; Zorn JR
    Mol Hum Reprod; 1996 Apr; 2(4):259-64. PubMed ID: 9238689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs.
    Bussenot I; Azoulay-Barjonet C; Parinaud J
    J Clin Endocrinol Metab; 1993 May; 76(5):1376-9. PubMed ID: 8496332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
    Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
    Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.
    Gründker C; Schlotawa L; Viereck V; Eicke N; Horst A; Kairies B; Emons G
    Eur J Endocrinol; 2004 Jul; 151(1):141-9. PubMed ID: 15248835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
    Kovacs M; Schally AV
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12197-202. PubMed ID: 11593037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.
    Qiao J; Lu G; Zhang HW; Chen H; Ma C; Olofsson JI; Witjes H; Heijnen E; Mannaerts B
    Gynecol Endocrinol; 2012 Oct; 28(10):800-4. PubMed ID: 22429192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
    European and Middle East Orgalutran Study Group
    Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
    Mannaerts B; Gordon K
    Hum Reprod; 2000 Sep; 15(9):1882-3. PubMed ID: 10966979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells.
    Kang SK; Tai CJ; Nathwani PS; Leung PC
    Endocrinology; 2001 Jan; 142(1):182-92. PubMed ID: 11145581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.